Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Apple
AAPL
|
+$3.09B |
| 2 |
Microsoft
MSFT
|
+$2.42B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$1.81B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.74B |
| 5 |
Amazon
AMZN
|
+$1.27B |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.54B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$549M |
| 3 |
Technology Select Sector SPDR Fund
XLK
|
+$452M |
| 4 |
Stellantis
STLA
|
+$326M |
| 5 |
SPDR S&P Biotech ETF
XBI
|
+$239M |
Sector Composition
| 1 | Technology | 29.05% |
| 2 | Healthcare | 11.56% |
| 3 | Financials | 10.8% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 7.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Athira Pharma
ATHA
$14.2M
| $646K | ﹤0.01% |
218,908
-17,210
| -7% | -$50.8K |
|
|
CHCT
2352
Community Healthcare Trust
CHCT
$445M
| $646K | ﹤0.01% |
19,589
+315
| +2% | +$10.4K |
|
2353
Montrose Environmental
MEG
$1.05B
| $645K | ﹤0.01% |
15,308
-1,967
| -11% | -$82.9K |
|
2354
Bilibili
BILI
$10.5B
| $644K | ﹤0.01% |
42,617
-353,465
| -89% | -$5.34M |
|
2355
Ginkgo Bioworks
DNA
$593M
| $644K | ﹤0.01% |
8,654
-11,001
| -56% | -$819K |
|
2356
Allient
ALNT
$779M
| $643K | ﹤0.01% |
16,108
+2,636
| +20% | +$105K |
|
2357
Payoneer
PAYO
$2.34B
| $641K | ﹤0.01% |
133,271
+11,541
| +9% | +$55.5K |
|
2358
Scholastic
SCHL
$691M
| $639K | ﹤0.01% |
16,405
+1,174
| +8% | +$45.7K |
|
2359
E.W. Scripps
SSP
$257M
| $639K | ﹤0.01% |
69,806
+12,142
| +21% | +$111K |
|
2360
Anika Therapeutics
ANIK
$125M
| $637K | ﹤0.01% |
24,556
+3,988
| +19% | +$103K |
|
2361
Arlo Technologies
ARLO
$1.82B
| $635K | ﹤0.01% |
58,193
-12,986
| -18% | -$142K |
|
2362
Baytex Energy
BTE
$1.83B
| $635K | ﹤0.01% |
194,757
+194,756
| +19,475,600% | +$635K |
|
|
FBRT
2363
Franklin BSP Realty Trust
FBRT
$935M
| $635K | ﹤0.01% |
44,935
+1,898
| +4% | +$26.8K |
|
2364
MillerKnoll
MLKN
$1.4B
| $633K | ﹤0.01% |
42,825
+3,426
| +9% | +$50.6K |
|
2365
Lyell Immunopharma
LYEL
$246M
| $630K | ﹤0.01% |
9,913
-2,350
| -19% | -$149K |
|
2366
Woodside Energy
WDS
$30.5B
| $630K | ﹤0.01% |
27,174
| – | – |
|
2367
ATN International
ATNI
$238M
| $629K | ﹤0.01% |
17,153
-136
| -0.8% | -$4.99K |
|
2368
Black Diamond Therapeutics
BDTX
$185M
| $628K | ﹤0.01% |
124,351
+105,000
| +543% | +$530K |
|
|
MRNS
2369
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $628K | ﹤0.01% |
57,884
-585,131
| -91% | -$6.35M |
|
|
TGI
2370
DELISTED
Triumph Group
TGI
| $627K | ﹤0.01% |
50,728
+6,471
| +15% | +$80K |
|
2371
Hillman Solutions
HLMN
$1.92B
| $626K | ﹤0.01% |
69,587
-53,110
| -43% | -$478K |
|
2372
Pilgrim's Pride
PPC
$10.4B
| $623K | ﹤0.01% |
29,011
+11,588
| +67% | +$249K |
|
2373
MacroGenics
MGNX
$100M
| $622K | ﹤0.01% |
116,540
-23,608
| -17% | -$126K |
|
2374
Full Truck Alliance
YMM
$14.2B
| $622K | ﹤0.01% |
100,000
-298,168
| -75% | -$1.85M |
|
2375
Healthcare Services Group
HCSG
$1.16B
| $620K | ﹤0.01% |
41,588
+2,338
| +6% | +$34.9K |
|